Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Galapagos ( (GLPG) ) has provided an update.
On December 8, 2025, Galapagos NV presented new Phase 2 data from its ATALANTA-1 study at the American Society of Hematology Annual Meeting, showcasing promising results for its CAR T-cell therapy candidate, GLPG5101, in treating mantle cell lymphoma (MCL). The study demonstrated high complete response rates and minimal residual disease negativity, with a short 7-day vein-to-vein time, allowing more patients to access treatment. Despite these positive outcomes, Galapagos announced its intention to wind down its cell therapy activities, subject to consultations in Belgium and the Netherlands, while remaining open to potential acquisition proposals.
The most recent analyst rating on (GLPG) stock is a Sell with a $22.00 price target. To see the full list of analyst forecasts on Galapagos stock, see the GLPG Stock Forecast page.
Spark’s Take on GLPG Stock
According to Spark, TipRanks’ AI Analyst, GLPG is a Neutral.
Galapagos’ overall stock score reflects a challenging financial and operational landscape. The company’s strong cash position and strategic partnerships are positive, but are overshadowed by significant operating losses, poor valuation metrics, and technical indicators suggesting potential downward pressure. Investors should be cautious and monitor the company’s ability to execute its strategic transformation and improve financial performance.
To see Spark’s full report on GLPG stock, click here.
More about Galapagos
Galapagos NV is a biotechnology company focused on developing innovative medicines. It operates in the pharmaceutical industry, primarily targeting hematological malignancies with its cell therapy products.
Average Trading Volume: 179,864
Technical Sentiment Signal: Sell
Current Market Cap: $2.08B
See more data about GLPG stock on TipRanks’ Stock Analysis page.